{"data":{"type":"feed_item","id":306614,"entity_id":"wefunder:feed_item:306614","attributes":{"canonical_url":"https://wefunder.com/feed/306614","retrieval_urls":{"canonical":"https://wefunder.com/feed/306614","json":"https://wefunder.com/feed/306614.json","markdown":"https://wefunder.com/feed/306614.md","ai_json":"https://wefunder.com/feed/306614.ai.json","ai_text":"https://wefunder.com/feed/306614.ai.txt","changelog_json":"https://wefunder.com/feed/306614.changelog.json","schema":"https://wefunder.com/.well-known/ai-profile-schema.json"},"updated_at":"2026-04-30T02:17:29.946Z","generated_at":"2026-06-24T08:16:17Z","profile_visibility":"public","feed_item":{"id":306614,"entity_id":"wefunder:feed_item:306614","type":"FeedItem::Update","title":"We Just Asked FDA for the Meeting That Unlocks Phase 3 | Sen-Jam Pharmaceutical","content_plain":"Dear Sen-Jam Investors \u0026amp; Community, On April 22, 2026, Sen-Jam Pharmaceutical submitted an End-of-Phase 2 meeting request to the U.S. Food and Drug Administration for SJP-001, our lead program. This is the regulatory hinge between completed ea...","published_at":"2026-04-23T14:10:31.318Z","updated_at":"2026-04-30T02:17:29.946Z","canonical_url":"https://wefunder.com/feed/306614","author":{"name":"Jim Iversen","profile_url":"https://wefunder.com/jimiversen2"},"subject":{"name":"Sen-Jam Pharmaceutical","profile_url":"https://wefunder.com/senjam"}},"provenance":{"source":"wefunder_public_feed_item","last_verified_at":"2026-04-30T02:17:29Z","claims":{"title":{"source":"feed_item.title","last_verified_at":"2026-04-30T02:17:29Z","as_of":"2026-04-30T02:17:29Z","confidence":"high"},"published_at":{"source":"feed_item.published_at","last_verified_at":"2026-04-30T02:17:29Z","as_of":"2026-04-23T14:10:31Z","confidence":"high"}}}}}}